Highlights
The Cross-Cohort Collaboration study provides a comprehensive analysis of the relationship between obesity severity and cardiovascular outcomes. Key highlights include:
- Class 3 obesity (BMI ≥40 kg/m2) is associated with a 3.0-fold increased risk of heart failure and a 2.8-fold increased risk of atrial fibrillation compared to normal-weight individuals.
- Significant sex-specific interactions were observed; women with severe obesity face higher relative increases in risk for stroke, total CVD, and all-cause mortality compared to men in the same BMI categories.
- The association between higher BMI and cardiovascular risk remains robust even after adjusting for traditional risk factors like hypertension and diabetes.
The Rising Burden of Severe Obesity
Obesity has long been recognized as a cornerstone risk factor for cardiovascular disease (CVD). However, as the global prevalence of severe obesity (Class 2 and Class 3) continues to climb, clinicians require more granular data to understand the long-term prognosis for these patients. Historically, many epidemiological studies grouped all individuals with a BMI over 30 into a single “obese” category, potentially masking the escalated risks associated with extreme weight. The Cross-Cohort Collaboration sought to fill this gap by analyzing the full spectrum of BMI across nine distinct cardiovascular and mortality outcomes.
Study Design and Methodology
This prospective analysis utilized data from 21 cohorts within the Cross-Cohort Collaboration, spanning participants enrolled between 1948 and 2015. The study included 289,875 individuals with a mean age of 60.3 years, of whom 79.2% were women. All participants had a baseline BMI of at least 18.5 kg/m2.
The research team focused on nine adjudicated outcomes over a median follow-up period of 19.2 years:
- Fatal and non-fatal myocardial infarction (MI)
- Fatal and non-fatal stroke
- Heart failure (HF)
- Atrial fibrillation (AF)
- Total coronary heart disease (CHD)
- Total cardiovascular disease (CVD)
- CHD mortality
- CVD mortality
- All-cause mortality
Multivariable Cox proportional hazard models with restricted cubic splines were employed to estimate the hazard ratios (HR) for each outcome, adjusting for age, sex, race, smoking status, and other clinical risk factors.
Key Findings: The Escalation of Risk
The study documented a staggering number of incident events during the follow-up period, including over 113,000 deaths and 14,000 heart failure events. The most striking findings were related to heart failure and atrial fibrillation.
Heart Failure and Atrial Fibrillation
Compared to individuals with a normal weight (BMI 18.5 to <25 kg/m2), those with Class 2 obesity (BMI 35 to <40 kg/m2) had a hazard ratio of 2.1 for HF. This risk escalated to an HR of 3.0 for those with Class 3 obesity (BMI ≥40 kg/m2). Similarly, for atrial fibrillation, the HR rose from 1.8 in Class 2 to 2.8 in Class 3. These findings suggest that severe obesity may exert a direct hemodynamic and structural strain on the heart, independent of other metabolic comorbidities.
Sex-Specific Risk Profiles
One of the most significant contributions of this study is the identification of sex-based differences in how obesity impacts cardiovascular health. While both men and women saw increased risks with higher BMI, the relative increase was more pronounced in women for certain outcomes. Specifically, the interaction for stroke, total CVD, and all-cause mortality was statistically significant (P < 0.001).
In men, the risk of stroke did not show a significant upward trend across higher BMI categories (P trend = 0.49). In contrast, women experienced a significant increase in stroke risk as BMI rose, though this risk appeared to plateau at the highest obesity levels. This suggests that the biological response to excess adiposity may differ between sexes, possibly due to variations in fat distribution (visceral vs. subcutaneous) or hormonal influences.
Expert Commentary: Mechanistic Insights
The robust association between severe obesity and heart failure/atrial fibrillation points toward specific pathophysiological mechanisms. Obesity is known to increase total blood volume and cardiac output, leading to left ventricular hypertrophy and diastolic dysfunction. Furthermore, adipose tissue acts as an active endocrine organ, secreting pro-inflammatory cytokines that can promote myocardial fibrosis and electrical remodeling, providing a substrate for atrial fibrillation.
The sex differences noted in the study are particularly intriguing for clinical practice. The higher relative risk in women for all-cause mortality and stroke at severe obesity levels suggests that weight management interventions may be particularly critical for female patients to prevent long-term neurological and systemic complications. Clinicians should be aware that the “obesity paradox”—a phenomenon where some studies suggest a protective effect of higher BMI in established disease—was not supported here in the context of primary incident events and long-term follow-up.
Study Limitations
While the study is powerful due to its size and duration, some limitations exist. BMI, while a standard metric, does not distinguish between muscle mass and fat mass, nor does it capture fat distribution. Additionally, while the models adjusted for traditional risk factors, the possibility of residual confounding remains. The cohorts also spanned several decades, during which preventive treatments (like statins and antihypertensives) and diagnostic criteria for conditions like HF and AF evolved significantly.
Conclusion
The Cross-Cohort Collaboration clarifies that the cardiovascular risks of obesity are not uniform but escalate dramatically with increasing severity. The tripling of heart failure risk in Class 3 obesity represents a major public health challenge. Furthermore, the discovery that women may be more vulnerable to the relative risks of obesity regarding stroke and mortality necessitates a more personalized approach to cardiovascular risk assessment. These findings underscore the urgent need for aggressive weight management strategies and public health policies aimed at preventing the progression from overweight to severe obesity.
References
1. Dardari ZA, Yao Z, Zhang J, et al. Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration. Circulation. 2026;153(10):720-735. PMID: 41674444.
2. Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984-e1010.
3. Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisited. European Cardiology Review. 2019;14(2):135.
